EN DE
Watch HST Global Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

HST Global Inc (HSTC) fair value: what the stock is really worth

As of Oct 19, 2026: fair value (intrinsic value) of HST Global Inc stock $0.37, price $0.70, that is 47.7% below the price, quality 42 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

HG HST Global Inc logo Thin data Nov 10, 2026

HST Global Inc

HSTC · US
Weakest Setup

Our calculation puts a fair price 48% below what the stock costs today.

Ranks above peers (5/7)
Quality 42/100
Fair value $0.3663 · Strongly overvalued
Weak Growth
Loss-making · -164.3% net margin (FY2025)
Negative free cash flow
Narrow moat 12/100
Thin data
Estimate⚠ Thinly traded
Watch HST Global Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.12 $0.0001 Fair Value $0.3663 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0001 – $1.12 · fair‑value band $0.2747 – $0.4578 · the $0.7000 price screens above the $0.3663 fair value. As of Nov 10, 2026.

Follow HST Global in your weekly email

Every Wednesday you see whether HST Global is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

HST Global, Inc. operates in the healthcare, software and media, and transportation industries. It offers Qwyit, a cryptographic protocol. HST Global, Inc. is based in Virginia Beach, Virginia.

Stock analysis

HST Global Inc (HSTC) currently trades at $0.7000, while our estimate is $0.3663, 48% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.2747 (bear) to $0.4578 (bull), the price of $0.7000 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

HST Global Inc reported revenue of $524K in FY2025 versus $0 in FY2020. Reported net income was −$861K in FY2025.

Key figures

Market cap $209M Micro · Return on equity −8.5% · Return on assets (EBIT) −35,950% (5-year average) · Free cash flow −$1.1M · Net debt $976K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 33% below its 52-week high and 1,011% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −48%, HSTC screens richer than that median.

Fair Value

Bear $0.2747 Fair Value $0.3663 Bull $0.4578
Price $0.7000 · Downside -47.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 85
Are margins and returns getting better?
Cashflow 17
Do the profits arrive as real cash?
Financial strength 75
Debt, balance sheet and risk of trouble
Investment 50
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 68
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 82
Distance to the 52-week high, does not count
New shares 39
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−66.7% (1986) → −154.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

HSTC screens overvalued: fair value 48% below the price. Compare with Vertex Pharmaceuticals Incorporated →

Compare HST Global Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 849 stocks

Beats the industry median on 4/6 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 42 · Above median
Fair Value upside −47.7% · Bottom 25%
Profitability
Return on assets −6.6% · Above median
Net margin (12 months) −164.3% · Bottom 25%
Operating margin (12 months) 0.0% · Above median
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Above median

Valuation Multiplesvs Biotechnology median · lower = cheaper

P/B 17.00× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Biotechnology stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Regeneron Pharmaceuticals, Inc REGN $916.06 $1,275 +39% vs HSTC
Samsung Biologics Co 207940 1,468,000 KRW 1,661,000 KRW +13% vs HSTC
Vertex Pharmaceuticals Incorporated VRTX $547.89 $601.80 +10% vs HSTC
Genmab A/S GMAB kr 3,581 kr 3,880 +8% vs HSTC
argenx SE ARGX $971.55 $908.40 −7% vs HSTC
CSL Limited CSL A$201.68 A$181.40 −10% vs HSTC
Moderna, Inc MRNA $250.83 $158.70 −37% vs HSTC
BeOne Medicines AG 6160 HK$252.20 HK$152.80 −39% vs HSTC
Celltrion, Inc 068270 203,000 KRW 74,945 KRW −63% vs HSTC
Royalty Pharma plc RPRX $69.45 $19.01 −73% vs HSTC

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HST Global Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "HST Global Inc Fair Value". https://www.fairvalue-calculator.com/stock/HSTC

Frequently asked questions

Is HST Global Inc (HSTC) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.3663 versus the last price from Oct 19, 2026 of $0.7000, about 48% lower (overvalued).
What is the fair value of HSTC?
Our estimate for HST Global Inc is $0.3663 (as of Nov 10, 2026), built from audited fundamentals. Last price (from Oct 19, 2026): $0.7000.
What is the quality score of HSTC?
HST Global Inc has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HST Global Inc (HSTC)?
Our calculated price target is the estimate of $0.3663 (as of Nov 10, 2026). Cautious scenario $0.2747, optimistic scenario $0.4578. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the HST Global Inc stock forecast for 2026?
Our estimate puts fair value at $0.3663, about 48% lower versus the last price from Oct 19, 2026 of $0.7000 (overvalued). Cautious scenario $0.2747, optimistic scenario $0.4578. The calculation is refreshed regularly with new filings.
What is the intrinsic value of HST Global Inc (HSTC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HST Global Inc it is $0.3663 per share (as of Nov 10, 2026), against a price of $0.7000.
Is HST Global Inc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, HSTC trades above its calculated fair value: price $0.7000, fair value $0.3663, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HSTC?
No. The price is what the market pays today ($0.7000); the fair value is what the company's own numbers justify ($0.3663). For HST Global Inc the two are $0.3337 per share apart. That gap is exactly why we show both numbers side by side.
How much is HST Global Inc worth?
The market values HST Global Inc at about $209M (market capitalisation, as of Nov 10, 2026). Per share that is $0.7000; our models calculate a fair value of $0.3663 per share.
What do the bullish and bearish scenarios say about HSTC?
Our models span a range for HST Global Inc: cautious scenario $0.2747, base $0.3663, optimistic $0.4578 per share (as of Nov 10, 2026, price $0.7000). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HST Global Inc (HSTC)?
Balance-sheet figures for HST Global Inc (as of Nov 10, 2026): return on equity −8.5%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is HSTC from its 52-week high?
HST Global Inc trades at $0.7000, about 33% below its 52-week high of $1.05 and 1,011% above the low of $0.0630 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3663 is for.
Which stocks are comparable to HST Global Inc?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Moderna, Inc, Regeneron Pharmaceuticals, Inc, CSL Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HST Global Inc stock attractive at the current price?
The data as of Nov 10, 2026: price $0.7000, calculated fair value $0.3663 (−48%), Quality Score 42/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. HST Global Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HST Global Inc (HSTC)?
The latest price we hold is from Oct 19, 2026 and stands at $0.7000. Our estimate is $0.3663, about 48% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HST Global Inc right now?
The price sits above even our optimistic bull case ($0.4578). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of HST Global Inc

How large is the market capitalisation of HST Global Inc (HSTC)?
The market capitalisation of HST Global Inc is $209M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the return on equity of HST Global Inc (HSTC)?
The return on equity (ROE) of HST Global Inc is −8.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HST Global Inc (HSTC)?
On an EBIT basis the return on assets of HST Global Inc is −35,950% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does HST Global Inc (HSTC) generate?
The free cash flow of HST Global Inc is −$1.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does HST Global Inc (HSTC) carry?
The net debt of HST Global Inc is $976K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch HST Global Inc in the live analysis

One click puts HST Global Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.